Source comparison
Best Sermorelin Dosage for Muscle Growth: Comparison
100–150mcg daily 150–250% 0.8–1.2kg <5% Minimal. Submaximal receptor occupancy Subtherapeutic for most research applications. Consistent GH elevation but insufficient IGF-1 response for measurable anabolism 200–300mcg daily 350–500% 1.5–2.5kg 8–12% Moderate. A
This comparison does not assign a generated winner or score.
- 100–150mcg daily
- 150–250%
- 0.8–1.2kg
- <5%
- Minimal. Submaximal receptor occupancy
- Subtherapeutic for most research applications. Consistent GH elevation but insufficient IGF-1 response for measurable anabolism
- 200–300mcg daily
- 350–500%
- 1.5–2.5kg
- 8–12%
- Moderate. Approaching optimal receptor binding
- Standard research dose. Balances efficacy and tolerability, aligns with most published protocols
- 400–500mcg daily
- 450–600%
- 2.0–3.0kg
- 15–22%
- High. Near-maximal receptor occupancy
- Upper threshold for muscle growth research. Marginal gains over 300mcg with increased flush/hypotension risk
- 600+mcg daily
- 500–650% (plateau)
- 2.1–3.2kg (minimal increase vs 400mcg)
- 25–35%
- Complete. No additional signaling capacity
- Exceeds receptor saturation point. No additional anabolic benefit, significantly higher adverse event rate
- The data reveals a clear inflection point: 300mcg produces 70–80% of the maximum achievable GH response while maintaining low side effect frequency. Doses above 400mcg push against the biological ceiling without proportional muscle growth returns.